Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0963 per EA under NDC 70010022801. Its NADAC has been published 117 times since Apr 3, 2024.
Strength
800 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010022801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA217116On Market Since
6/27/2023
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 117 times since Apr 3, 2024, and over the history we have for it it has declined 20.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $0.1215 (Apr 10, 2024) |
| All-time low | $0.0799 (Nov 20, 2024) |
| 52-week high | $0.1035 |
| 52-week low | $0.0963 |
| Median price | $0.1016 |
| Average price | $0.1018 |
| Largest weekly change | -27.0% (Nov 20, 2024) |
| Weeks tracked | 117 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 21 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.0963 per EA (NDC 70010022801), effective Jun 24, 2026.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 20.7%. It has been tracked across 117 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Apr 3, 2024, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1215 (Apr 10, 2024), with a median of $0.1016 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
21 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 800 MG TABLET, but none are currently priced below it.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 70010022801) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification